Understanding New Options for Non

Find out about non-Hodgkin lymphoma treatment options and how the latest advancements may affect your care.

Non-Hodgkin Lymphoma Treatment Options Understanding the various non-Hodgkin lymphoma treatment options is crucial for patients and their families navigating this complex diagnosis. This article provides a comprehensive overview of current therapies, from conventional approaches to cutting-edge advancements, to help inform and empower individuals.
Key Details About Understanding New Options For Non Hodgkin Lymphoma

Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. Learn more about types of NHL and treatments in this expert-reviewed summary.
Research into the causes, prevention, and treatment of non-Hodgkin lymphoma is being done in many medical centers throughout the world. Learn more.

Advances in Lymphoma Research
Find what's new in Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) treatment and research, including progress on targeted therapies and immunotherapies. Selected NCI-supported lymphoma programs are also described.
Explore the latest ASH 2025 breakthroughs in non-Hodgkin lymphoma , including CAR-T durability, bispecific antibody combinations, and new FDA-approved treatments for DLBCL and follicular lymphoma .

The Future of Lymphoma Therapy
The Future of Lymphoma Therapy: Expert Perspectives After ASH Treatment News Coming Out of the American Society of Hematology Annual Conference We're talking about the two most common subtypes of non-Hodgkin lymphoma : diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma . We recently had a meeting of minds from all over the world at the 2024 American Society of Hematology (ASH ...
Learn about the most effective Non-Hodgkin Lymphoma treatment options with the fewest side effects. Customized treatments options : 1. Chemotherapy 2. Radiation 3. Proton Therapy.

Treating Non
Treating Non-Hodgkin Lymphoma If you've been diagnosed with non-Hodgkin lymphoma (NHL), your cancer care team will discuss your options with you. It's important to weigh the benefits of each treatment option against the possible risks and side effects.








BTK inhibitors, for example, are especially helpful in treating rare types of lymphoma such as chronic lymphocytic leukemia and mantle cell lymphoma . "These therapies offer new avenues for patients, particularly for those with difficult-to-treat lymphoma or disease that's come back or stopped responding to treatment," says Dr. Moustafa.